Flashcards · Module 1
🧬 Why Do We Age?
4 of 4 cards published · read by the site’s author on 13 November 2026
What are the 3 evolutionary theories of aging?
Needs clinical review
Think of it like this:
Imagine evolution is a factory manager who only cares about making babies (reproduction). Once you've had kids, the manager stops investing in your maintenance.
The 3 Theories:
| Theory | Scientist | Simple Explanation |
|---|---|---|
| Mutation Accumulation | Medawar (1952) | Bad genes that only cause problems in old age pile up because evolution can't "see" them — most animals die young in the wild anyway |
| Antagonistic Pleiotropy | Williams (1957) | Some genes are helpful when young but harmful when old (e.g., strong bones for reproduction → calcium clogs arteries later) |
| Disposable Soma | Kirkwood (1977) | Your body has limited energy — evolution spends it on making babies, not repairing your body forever |
Sources checked (2) · 12 November 2026
What is Progeria (HGPS), and why does it teach us about normal aging?
Needs clinical review
The Story:
A child ages rapidly and dies around age 14 from a heart attack. Why?
The Genetics (step by step):
A single silent mutation in the LMNA gene:
c.1824C>TThis creates a wrong splicing site → deletes 50 amino acids from a protein called prelamin A
Normally, an enzyme called ZMPSTE24 trims prelamin A into its final form (lamin A)
But the 50-aa deletion removes the ZMPSTE24 cutting site ✂️
Result: a permanently stuck, toxic protein called PROGERIN gets trapped in the nuclear membrane
This causes the cell nucleus to bleb and crumble → DNA damage → premature death
Why it matters for normal aging:
Even healthy old people make small amounts of progerin in their tissues → raising the possibility that similar mechanisms contribute slowly in all of us.
Treatment:
Lonafarnib (a farnesyltransferase inhibitor) — blocks the chemical "glue" that sticks progerin to the nuclear membrane.
Sources checked (2) · 12 November 2026
Note: In HGPS, lonafarnib extends median survival by approximately 2.5 years and has received FDA approval as a disease-modifying therapy. (The Lamin Proteins in Nuclear Structure, Functions, and Laminopathies (2026))
What is the SASP and why are "zombie cells" dangerous?
Needs clinical review
Think of it like this:
Imagine a cell gets damaged so badly it can't divide anymore — but it also refuses to die. It becomes a zombie cell (senescent cell). Worse, it starts spewing toxic chemicals at its neighbors.
How cells become senescent:
Two molecular brakes slam on permanently:
p53 → p21 pathway (DNA damage alarm)
p16 → Rb pathway (stress/oncogene alarm)
The SASP (Senescence-Associated Secretory Phenotype):
These zombie cells pump out a toxic cocktail:
🔴 Inflammatory cytokines: IL-6, IL-1β, TNF-α
🔴 Tissue-destroying enzymes: MMP-1, MMP-3, MMP-9
🔴 Chemokines: IL-8, MCP-1 (attract immune cells, causing more damage)
Why this matters:
The SASP is contagious — it turns healthy neighbor cells senescent too! This is a major driver of inflammaging (chronic low-grade inflammation of aging).
Treatment frontier — Senolytics:
Drugs that selectively kill zombie cells while sparing normal cells:
Dasatinib + Quercetin (D+Q)
Fisetin (a natural flavonoid)
Sources checked (4) · 12 November 2026
- Paeonol Attenuates UVB-Induced Premature Senescence in Human Dermal Fibroblasts to Promote Skin Longevity (2026)
- Cellular senescence: six decades of discovery and reinvention (2026)
- Senescence-Associated Secretory Phenotype (SASP) and Atherosclerotic Plaque Inflammation: Natural Product-Based Interventions and Implications for Personalized Therapy (2026)
- The vicious cycle of SASP and inflammaging promotes aging and age-related diseases (2026)
Note: Evidence for clinical benefit from senolytics remains preliminary in early-stage clinical evaluation. (Cellular senescence: six decades of discovery and reinvention (2026))
Note: In the United States, quercetin and fisetin are sold as dietary supplements under the Dietary Supplement Health and Education Act of 1994, with no premarket proof of efficacy and no permitted claim to treat or prevent disease. (Senescence-Associated Secretory Phenotype (SASP) and Atherosclerotic Plaque Inflammation: Natural Product-Based Interventions and Implications for Personalized Therapy (2026))
What is Allostatic Load? (The McEwen Model)
Needs clinical review
Simple Analogy:
Think of your body as a car engine. Revving the engine occasionally (acute stress) is normal. But if you never turn the engine off, the parts wear out faster.
The 3 Levels of Damage:
| Level | What's Happening | Examples |
|---|---|---|
| Primary Mediators | Stress hormones fire | Cortisol ↑, Adrenaline ↑, IL-6 ↑ |
| Secondary Outcomes | Body starts showing subclinical wear | HbA1c ↑, Belly fat ↑, Blood pressure ↑, HDL ↓, CRP ↑ |
| Tertiary Disease | Organs fail | Diabetes, Heart attacks, Strokes, Depression, Frailty |
McEwen's 4 Types of Overload:
🔁 Repeated hits — stress keeps coming (e.g., daily workplace abuse)
🔄 No adaptation — you never get used to the stress
⏳ Prolonged response — stress is gone, but cortisol stays high
⬇️ Inadequate response — cortisol too low → inflammation runs wild
Sources checked (8) · 12 November 2026
- Protective and damaging effects of stress mediators: central role of the brain (2006)
- Advancing the allostatic load model in military training research: from theory to application (2025)
- Assessing Measurement Invariance in Allostatic Load between Black and White Adolescents (2026)
- Allostatic Load, Social Participation, and Healthy Ageing: Longitudinal Evidence on the Impact of Chronic Stress (2025)
- Neurobiological and Anti-Inflammatory Effects of a Deep Diaphragmatic Breathing Technique Based on Neofunctional Psychotherapy: A Pilot RCT (2024)
- The Longitudinal Relationship Between Allostatic Load and Multimorbidity Among Older Americans (2025)
- Allostatic Load and Severe Clinical Phenotypes in Major Depressive Disorder: A Cross-Sectional Statistical Mediation Analysis of Perceived Stress, Cognitive Impairment, and Suicidal Ideation (2026)
- Association of allostatic load with frailty trajectories and the mediating role of depressive symptoms (2026)
Note: Primary mediators are defined in some literature as cortisol, dehydroepiandrosterone (DHEA), epinephrine, and norepinephrine due to their direct link with adrenal function, whereas other authors include cytokines. (The Longitudinal Relationship Between Allostatic Load and Multimorbidity Among Older Americans (2025))
Note: Secondary mediators include biomarkers such as cholesterol, glycosylated haemoglobin, resting systolic and diastolic blood pressure, c-reactive protein, and waist/hip ratio. (The Longitudinal Relationship Between Allostatic Load and Multimorbidity Among Older Americans (2025))
Note: The link with frailty is not found in every study: in one community-based study, age, sex and place of residence, but not allostatic load, were associated with frailty. (Association of allostatic load with frailty trajectories and the mediating role of depressive symptoms (2026))